VP4-2023: Sotorasib 960 mg versus 240 mg in pretreated KRAS G12C advanced NSCLC
M. J. Hochmair,K. Vermaelen,G. Mountzios,E. Carcereny,C. Dooms,S. -h. Lee,E. M. Morocz,T. Kato,T-e. Ciuleanu,G. Dy,M. B. M. C. S. Parente,K. J. O'Byrne,Q. s -c. Chu,G. De Castro Jr,N. Girard,W. Snyder,Q. Tran,W. Kormany,B. Houk,A. Curioni-Fontecedro
